: Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts say

DexCom’s strong quarterly results give device makers a boost.

Previous post The Ratings Game: Chipotle’s Q3 results could make it a standout in restaurant earnings season
Next post Litecoin sees a spike in on-chain activity- but what’s next for LTC?